For the fiscal year ending March 2026, sales reached 290.7 billion yen (YoY +8.3%), operating income was 14.8 billion yen, and net income was 7.4 billion yen, achieving both revenue growth and profit increase. Future outlook remains robust.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3034","jir_company_name":"Quol Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/3034-20260514-01.pdf","jir_short_summary":"For the fiscal year ending March 2026, sales reached 290.7 billion yen (YoY +8.3%), operating income was 14.8 billion yen, and net income was 7.4 billion yen, achieving both revenue growth and profit increase. Future outlook remains robust.","jir_summary":"### Performance Overview\nQuol Holdings Co., Ltd. achieved sales of 290.7 billion yen (YoY +8.3%), operating income of 14.8 billion yen (+11.4%), and net income of 7.4 billion yen (+5.3%) for the fiscal year ending March 2026. The expansion of pharmaceuticals sales and dispensing services strengthened the earnings base. Along with sales growth, profit margins also improved, demonstrating stable growth.\n\n### Future Outlook\nThe company will continue expanding its healthcare and dispensing businesses, strengthening existing stores and opening new ones. The medium-term management plan targets sales of 350 billion yen and operating income of 20 billion yen, aiming for sustainable growth and profitability improvement. Additionally, efforts toward environmental sustainability and ESG initiatives will be prioritized to enhance corporate value.","jir_financial_highlights":"Sales: 290.7 billion yen (YoY +8.3%)\nOperating Income: 14.8 billion yen (YoY +11.4%)\nNet Income: 7.4 billion yen (YoY +5.3%)","jir_category":"","jir_hashtags":"#QuolHoldings, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Sales: 290.7 billion yen (YoY +8.3%)\nOperating Income: 14.8 billion yen (YoY +11.4%)\nNet Income: 7.4 billion yen (YoY +5.3%)","jir_meta_title":"\u3010Quol HD\u3011Results for the Fiscal Year Ending March 2026 | Sales of 290.7 billion yen (YoY +8.3%)","jir_meta_description":"Quol Holdings achieved sales of 290.7 billion yen (YoY +8.3%), operating income of 14.8 billion yen, and net income of 7.4 billion yen for the fiscal year ending March 2026. Continued growth is planned.","jir_og_title":"\u3010Quol HD\u3011Results for the Fiscal Year Ending March 2026 | Sales of 290.7 billion yen (YoY +8.3%)","jir_og_description":"Quol Holdings' fiscal year ending March 2026 reports sales of 290.7 billion yen, increasing revenue and profits. Expansion of healthcare business will continue.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Sales Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2024\\\",\\\"2025\\\",\\\"2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Sales\\\",\\\"data\\\":[2500,2700,2907],\\\"borderColor\\\":\\\"#36A2EB\\\",\\\"fill\\\":false}]}},\\\"options\\\":{}\"}, {\"jir_chart_id\": \"profit_margin\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Profit Margin Trends\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2024\\\",\\\"2025\\\",\\\"2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin\\\",\\\"data\\\":[5.9,5.5,5.1],\\\"backgroundColor\\\":\\\"#FF6384\\\"}]}},\\\"options\\\":{}\"}]","ir_related_company":16824,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-50936","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n